Pharmaceutical company
Active 2007–2026. The register lists this client once for every firm that files on its behalf; all 3 of its records are shown together here.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2026 | SL STRATEGIES, LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$40,000 | |
| 2026 | SL STRATEGIES, LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$40,000 | |
| 2026 | SL STRATEGIES, LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$40,000 | |
| 2025 | SL STRATEGIES, LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$40,000 | |
| 2025 | SL STRATEGIES, LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$40,000 | |
| 2025 | SL STRATEGIES, LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$40,000 | |
| 2025 | SL STRATEGIES, LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$40,000 | |
| 2024 | SL STRATEGIES, LLC |
4th Quarter (Oct 1 - Dec 31) AMENDED |
$40,000 | |
| 2024 | SL STRATEGIES, LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$40,000 | |
| 2024 | SL STRATEGIES, LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$40,000 |
| Firm | Filings | Amount |
|---|---|---|
| SL STRATEGIES, LLC | 41 | $1,510,000 |
| FUNDERBURK CONSULTING LLC | 4 | $40,000 |
| SQUIRE PATTON BOGGS | 3 | — |
| Issue | Activities |
|---|---|
| Budget/Appropriations | 44 |
| Health Issues | 43 |
| Defense | 9 |
| Medical/Disease Research/Clinical Labs | 2 |
| Disaster Planning/Emergencies | 2 |
| Homeland Security | 1 |
| Science/Technology | 1 |
| Pharmacy | 1 |
| Trade (domestic/foreign) | 1 |